The Latest Cardiac and Vascular News
– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is a devastating condition for more than 5 million patients in the United States NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron, an endovascular brain-computer (BCI) interface company, today announced the enrollment of […]
With the Avail Platform, Collaborators participating in STAR — the Stroke Thrombectomy and Aneurysm Registry — Can Lean on each other and Work Together, Regardless of Location or Hour SANTA CLARA, Calif., May 3, 2022 /PRNewswire/ — Avail Medsystems, a healthcare technology company whose surgical telepresence platform facilitates real-time, interactive collaboration during live procedures among […]
ANA System Shown to Achieve High Rate of Complete Recanalization, Favorable 90 Day Outcomes BARCELONA, Spain–(BUSINESS WIRE)–Multi-center clinical study data supporting Anaconda Biomed’s ANA Advanced Neurovascular Access™ (ANA) Catheter System for treating ischemic stroke has been published in the journal Stroke. The SOLONDA (“SOL”itaire in combination with the ANA Catheter system manufactured […]
Transparent 3D models allow MedTech companies to train physicians on new devices outside the cath lab BOSTON, March 31, 2022 /PRNewswire/ — Biomodex®, the leader in biorealistic haptic simulators for physician training and rehearsals, today announced the launch of Clear Cartridges for use with all Biomodex EVIAS™ and EVIAS Plus™ stations. The anatomically accurate clear cartridges […]
– Company Announces Expansion of its Contour Neurovascular System™ Platform – FREMONT, Calif. and OXFORD, England, March 23, 2022 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 027 micro-catheters, available in two lengths, expanding […]
MINNEAPOLIS, March 21, 2022 /PRNewswire/ — The use of medications and exercise is more beneficial in preventing a second stroke in people with intracranial atherosclerosis than placing a stent in the blood vessel, according to a new practice advisory issued by the American Academy of Neurology (AAN). The practice advisory is published in the March 21, […]
TEL AVIV, Israel, Feb. 28, 2022 /PRNewswire/ — The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of capital raising from Philips together with Sanara Capital. The Israeli Rad Biomed investment fund led […]
ALISO VIEJO, Calif., Feb. 22, 2022 /PRNewswire/ — MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia. MicroVention received FDA PMA approval for the FRED X device in September […]
TACOMA, Wash.–(BUSINESS WIRE)–Revalesio, a clinical-stage pharmaceutical company developing treatments for neurological diseases, presented the design of its recently launched RESCUE Phase 2 clinical trial evaluating RNS60 as a treatment for large vessel occlusion acute ischemic stroke (AIS), as well as new preclinical data supporting the advancement of RNS60 for AIS. […]
Sovateltide is an endothelin B receptor agonist that increases blood flow, shows anti-apoptotic activity, protects neural mitochondria, and produces neurovascular remodeling WILLOWBROOK, Ill., Feb. 17, 2022 (GLOBE NEWSWIRE) — Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care, announced today […]
